Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
2.068B
Cash
552.9M
Avg Qtr Burn
-15.93M
Short % of Float
13.34%
Insider Ownership
7.00%
Institutional Own.
84.62%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Cretostimogene Details Non-muscle invasive bladder cancer, Cancer | Phase 3 Data readout | |
Cretostimogene Details Non-muscle invasive bladder cancer, Cancer Big Mover™ Suspected Mover™ Susp. Mover™ | Phase 3 Data readout | |
Cretostimogene + KEYTRUDA Details Non-muscle invasive bladder cancer, Cancer | Phase 2 Update | |
Cretostimogene Details Non-muscle invasive bladder cancer, Cancer | Phase 2 Initiation |